ArticleFrontiers in oncology2026
Case Report: Long-term survival with erlotinib for lung cancer with secondary leptomeningeal carcinomatosis.
Diego Neira et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it